vs
Kosmos Energy Ltd.（KOS）与P3 Health Partners Inc.（PIII）财务数据对比。点击上方公司名可切换其他公司
P3 Health Partners Inc.的季度营收约是Kosmos Energy Ltd.的1.3倍（$384.8M vs $294.6M），P3 Health Partners Inc.同比增速更快（3.8% vs -25.9%），过去两年P3 Health Partners Inc.的营收复合增速更高（-0.5% vs -16.5%）
科斯莫斯能源是一家美国上游石油企业，总部位于得克萨斯州达拉斯。公司目前在加纳、赤道几内亚近海以及墨西哥湾开展油气生产与开发业务，在毛里塔尼亚、塞内加尔近海拥有开发项目，还在纳米比亚、圣多美和普林西比、苏里南近海持有勘探许可。
P3 Health Partners Inc.是一家总部位于美国的人口健康管理与价值型医疗服务企业，与基层医疗机构及医疗系统合作，为包括联邦医保优势计划参保者在内的人群提供协同优质医疗服务，致力于提升诊疗效果、降低不必要的医疗开支。
KOS vs PIII — 直观对比
营收规模更大
PIII
是对方的1.3倍
$294.6M
营收增速更快
PIII
高出29.7%
-25.9%
两年增速更快
PIII
近两年复合增速
-16.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $294.6M | $384.8M |
| 净利润 | — | $-75.5M |
| 毛利率 | — | — |
| 营业利润率 | -125.7% | -40.0% |
| 净利率 | — | -19.6% |
| 营收同比 | -25.9% | 3.8% |
| 净利润同比 | — | -28.8% |
| 每股收益（稀释后） | $-0.80 | $-23.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KOSPIII
| Q4 25 | $294.6M | $384.8M | ||
| Q3 25 | $311.0M | $345.3M | ||
| Q2 25 | $392.6M | $355.8M | ||
| Q1 25 | $290.1M | $373.2M | ||
| Q4 24 | $397.6M | $370.7M | ||
| Q3 24 | $407.8M | $362.1M | ||
| Q2 24 | $447.8M | $379.2M | ||
| Q1 24 | $422.3M | $388.5M |
净利润KOSPIII
| Q4 25 | — | $-75.5M | ||
| Q3 25 | $-124.3M | $-31.6M | ||
| Q2 25 | $-87.7M | $-20.4M | ||
| Q1 25 | $-110.6M | $-20.5M | ||
| Q4 24 | — | $-58.6M | ||
| Q3 24 | $45.0M | $-46.5M | ||
| Q2 24 | $59.8M | $-12.0M | ||
| Q1 24 | $91.7M | $-18.7M |
营业利润率KOSPIII
| Q4 25 | -125.7% | -40.0% | ||
| Q3 25 | -34.2% | -12.8% | ||
| Q2 25 | -16.2% | -9.6% | ||
| Q1 25 | -32.4% | -10.2% | ||
| Q4 24 | -8.5% | -37.4% | ||
| Q3 24 | 26.1% | -29.5% | ||
| Q2 24 | 30.2% | -8.3% | ||
| Q1 24 | 33.6% | -11.3% |
净利率KOSPIII
| Q4 25 | — | -19.6% | ||
| Q3 25 | -40.0% | -9.1% | ||
| Q2 25 | -22.3% | -5.7% | ||
| Q1 25 | -38.1% | -5.5% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | 11.0% | -12.8% | ||
| Q2 24 | 13.3% | -3.2% | ||
| Q1 24 | 21.7% | -4.8% |
每股收益（稀释后）KOSPIII
| Q4 25 | $-0.80 | $-23.08 | ||
| Q3 25 | $-0.26 | $-9.67 | ||
| Q2 25 | $-0.18 | $-6.23 | ||
| Q1 25 | $-0.23 | $-6.28 | ||
| Q4 24 | $0.00 | $-23.13 | ||
| Q3 24 | $0.09 | $-15.70 | ||
| Q2 24 | $0.12 | $-7.37 | ||
| Q1 24 | $0.19 | $-7.86 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $91.5M | $25.0M |
| 总债务越低越好 | $3.1B | $228.4M |
| 股东权益账面价值 | $528.6M | $-155.2M |
| 总资产 | $4.7B | $656.6M |
| 负债/权益比越低杠杆越低 | 5.78× | — |
8季度趋势，按日历期对齐
现金及短期投资KOSPIII
| Q4 25 | $91.5M | $25.0M | ||
| Q3 25 | $64.0M | $37.7M | ||
| Q2 25 | $51.7M | $38.6M | ||
| Q1 25 | $49.8M | $40.1M | ||
| Q4 24 | $85.0M | $38.8M | ||
| Q3 24 | $51.6M | $63.0M | ||
| Q2 24 | $173.8M | $73.1M | ||
| Q1 24 | $254.3M | $27.3M |
总债务KOSPIII
| Q4 25 | $3.1B | $228.4M | ||
| Q3 25 | $3.0B | $252.8M | ||
| Q2 25 | $2.9B | $182.0M | ||
| Q1 25 | — | $171.1M | ||
| Q4 24 | $2.7B | $108.9M | ||
| Q3 24 | — | $133.2M | ||
| Q2 24 | — | $133.1M | ||
| Q1 24 | — | $118.1M |
股东权益KOSPIII
| Q4 25 | $528.6M | $-155.2M | ||
| Q3 25 | $898.8M | $-18.7M | ||
| Q2 25 | $1.0B | $44.5M | ||
| Q1 25 | $1.1B | $63.3M | ||
| Q4 24 | $1.2B | $75.9M | ||
| Q3 24 | $1.2B | $120.5M | ||
| Q2 24 | $1.1B | $166.8M | ||
| Q1 24 | $1.1B | $146.6M |
总资产KOSPIII
| Q4 25 | $4.7B | $656.6M | ||
| Q3 25 | $5.1B | $683.6M | ||
| Q2 25 | $5.2B | $731.6M | ||
| Q1 25 | $5.3B | $783.9M | ||
| Q4 24 | $5.3B | $783.4M | ||
| Q3 24 | $5.5B | $833.3M | ||
| Q2 24 | $5.4B | $892.8M | ||
| Q1 24 | $5.4B | $855.9M |
负债/权益比KOSPIII
| Q4 25 | 5.78× | — | ||
| Q3 25 | 3.31× | — | ||
| Q2 25 | 2.80× | 4.09× | ||
| Q1 25 | — | 2.71× | ||
| Q4 24 | 2.29× | 1.43× | ||
| Q3 24 | — | 1.11× | ||
| Q2 24 | — | 0.80× | ||
| Q1 24 | — | 0.81× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $35.3M | $-25.7M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流KOSPIII
| Q4 25 | $35.3M | $-25.7M | ||
| Q3 25 | $-27.6M | $-15.4M | ||
| Q2 25 | $127.2M | $-16.6M | ||
| Q1 25 | $-888.0K | $-33.5M | ||
| Q4 24 | $175.7M | $-57.2M | ||
| Q3 24 | $6.3M | $-22.6M | ||
| Q2 24 | $223.7M | $-10.2M | ||
| Q1 24 | $272.6M | $-20.0M |
资本支出强度KOSPIII
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率KOSPIII
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 3.74× | — | ||
| Q1 24 | 2.97× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KOS
| Ghana Segment | $134.6M | 46% |
| Gulf Of America | $80.7M | 27% |
| Mauritania And Senegal | $54.9M | 19% |
| Equatorial Guinea Segment | $24.3M | 8% |
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
